ACYCLOVIR suspension United States - English - NLM (National Library of Medicine)

acyclovir suspension

actavis pharma, inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 200 mg in 5 ml - herpes zoster infections: acyclovir is indicated for the acute treatment of herpes zoster (shingles). genital herpes: acyclovir is indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. chickenpox: acyclovir is indicated for the treatment of chickenpox (varicella). acyclovir oral suspension is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.

ACYCLOVIR capsule United States - English - NLM (National Library of Medicine)

acyclovir capsule

carlsbad technology, inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 200 mg - herpes zoster infections : acyclovir is indicated for the acute treatment of herpes zoster (shingles). genital herpes : acyclovir is indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. chickenpox : acyclovir is indicated for the treatment of chickenpox (varicella). acyclovir is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.

ACYCLOVIR ointment United States - English - NLM (National Library of Medicine)

acyclovir ointment

tolmar inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 50 mg in 1 g - acyclovir ointment, 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment, 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.

ACYCLOVIR ointment United States - English - NLM (National Library of Medicine)

acyclovir ointment

glenmark pharmaceuticals inc., usa - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 50 mg in 1 g - acyclovir ointment usp 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.

ACYCLOVIR ointment United States - English - NLM (National Library of Medicine)

acyclovir ointment

e. fougera & co. a division of fougera pharmaceuticals inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 50 mg in 1 g - acyclovir ointment usp 5% is indicated in the management of initial genital herpes and in limited non- life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment usp 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.

VALACYCLOVIR HYDROCHLORIDE- valacyclovir hydrochloride tablet United States - English - NLM (National Library of Medicine)

valacyclovir hydrochloride- valacyclovir hydrochloride tablet

nucare pharmaceuticals,inc. - valacyclovir hydrochloride (unii: g447s0t1vc) (acyclovir - unii:x4hes1o11f) - valacyclovir 1000 mg - cold sores (herpes labialis): valacyclovir tablets, usp are indicated for treatment of cold sores (herpes labialis). the efficacy of valacyclovir tablets, usp initiated after the development of clinical signs of a cold sore (e.g., papule, vesicle, or ulcer) has not been established. genital herpes: initial episode: valacyclovir tablets, usp are indicated for treatment of the initial episode of genital herpes in immunocompetent adults. the efficacy of treatment with valacyclovir tablets, usp when initiated more than 72 hours after the onset of signs and symptoms has not been established. recurrent episodes: valacyclovir tablets, usp are indicated for treatment of recurrent episodes of genital herpes in immunocompetent adults. the efficacy of treatment with valacyclovir tablets, usp when initiated more than 24 hours after the onset of signs and symptoms has not been established. suppressive therapy: valacyclovir tablets, usp are indicated for chronic suppressive therapy of recurrent episodes of genital her

VALACYCLOVIR HYDROCHLORIDE- valacyclovir hydrochloride tablet, film coated United States - English - NLM (National Library of Medicine)

valacyclovir hydrochloride- valacyclovir hydrochloride tablet, film coated

actavis pharma, inc. - valacyclovir hydrochloride (unii: g447s0t1vc) (acyclovir - unii:x4hes1o11f) - valacyclovir 500 mg - cold sores (herpes labialis): valacyclovir tablets are indicated for treatment of cold sores (herpes labialis). the efficacy of valacyclovir hydrochloride initiated after the development of clinical signs of a cold sore (e.g., papule, vesicle, or ulcer) has not been established. genital herpes: initial episode: valacyclovir tablets are indicated for treatment of the initial episode of genital herpes in immunocompetent adults. the efficacy of treatment with valacyclovir hydrochloride when initiated more than 72 hours after the onset of signs and symptoms has not been established. recurrent episodes: valacyclovir tablets are indicated for treatment of recurrent episodes of genital herpes in immunocompetent adults. the efficacy of treatment with valacyclovir hydrochloride when initiated more than 24 hours after the onset of signs and symptoms has not been established. suppressive therapy: valacyclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes in immunocomp

VALACYCLOVIR HYDROCHLORIDE- valacyclovir hydrochloride tablet United States - English - NLM (National Library of Medicine)

valacyclovir hydrochloride- valacyclovir hydrochloride tablet

remedyrepack inc. - valacyclovir hydrochloride (unii: g447s0t1vc) (acyclovir - unii:x4hes1o11f) - valacyclovir 500 mg - cold sores (herpes labialis): valacyclovir tablets, usp are indicated for treatment of cold sores (herpes labialis). the efficacy of valacyclovir tablets, usp initiated after the development of clinical signs of a cold sore (e.g., papule, vesicle, or ulcer) has not been established. genital herpes: initial episode: valacyclovir tablets, usp are indicated for treatment of the initial episode of genital herpes in immunocompetent adults. the efficacy of treatment with valacyclovir tablets, usp when initiated more than 72 hours after the onset of signs and symptoms has not been established. recurrent episodes: valacyclovir tablets, usp are indicated for treatment of recurrent episodes of genital herpes in immunocompetent adults. the efficacy of treatment with valacyclovir tablets, usp when initiated more than 24 hours after the onset of signs and symptoms has not been established. suppressive therapy: valacyclovir tablets, usp are indicated for chronic suppressive therapy of recurrent episodes of genital her

ACYCLOVIR- acyclovir suspension United States - English - NLM (National Library of Medicine)

acyclovir- acyclovir suspension

atlantic biologicals corps - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 200 mg in 5 ml - acyclovir oral suspension, usp is indicated for the acute treatment of herpes zoster (shingles). acyclovir oral suspension, usp is indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. acyclovir oral suspension, usp is indicated for the treatment of chickenpox (varicella). acyclovir is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.

ACYCLOVIR- acyclovir tablet United States - English - NLM (National Library of Medicine)

acyclovir- acyclovir tablet

remedyrepack inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 800 mg - herpes zoster infections: acyclovir tablets are indicated for the acute treatment of herpes zoster (shingles). genital herpes: acyclovir tablets are indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. chickenpox: acyclovir tablets are indicated for the treatment of chickenpox (varicella). acyclovir tablets are contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.